CPIX
Cumberland Pharmaceuticals Inc.NASDAQHealthcare$3.10-2.21%ClosedMarket Cap: $46.4M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
1.86
P/S
1.04
EV/EBITDA
16.79
DCF Value
$1.12
FCF Yield
10.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.0%
Operating Margin
-6.3%
Net Margin
-6.4%
ROE
-10.5%
ROA
-3.7%
ROIC
-6.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $13.7M | 83.6% | $-1.4M | $-1.4M | $-0.09 | — |
| FY 2025 | $44.5M | 85.0% | $-2.8M | $-2.8M | $-0.19 | — |
| Q3 2025 | $8.3M | 88.1% | $-2.0M | $-1.9M | $-0.13 | — |
| Q2 2025 | $10.8M | 81.4% | $-747.5K | $-740.7K | $-0.05 | — |
| Q1 2025 | $11.7M | 87.8% | $1.3M | $1.3M | $0.08 | — |
| Q4 2024 | $10.4M | 81.1% | $-1.8M | $-1.9M | $-0.14 | — |
| FY 2024 | $37.9M | 82.6% | $-6.4M | $-6.5M | $-0.46 | — |
| Q3 2024 | $9.1M | 85.4% | $-1.7M | $-1.5M | $-0.11 | — |
| Q2 2024 | $9.8M | 82.6% | $-1.0M | $-1.1M | $-0.08 | — |
| Q1 2024 | $8.5M | 81.5% | $-1.9M | $-1.9M | $-0.14 | — |
| Q4 2023 | $9.4M | 83.6% | $-6.2M | $-6.3M | $-0.44 | — |
| FY 2023 | $39.6M | 84.7% | $-9.6M | $-6.3M | $-0.44 | — |